SPI Pharma Inc – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

SPI Pharma Inc (SPI Pharma), a subsidiary of SPI Holdings Inc. provides pharmaceutical ingredients and technologies for patient-friendly dosage forms. The company undertakes the manufacturing and marketing of various pharmaceutical products and technologies to solve challenging formulation problems. It offers a wide range of pharmaceuticals products which contain antacid actives, soluble excipients, taste-masking technology actives, vaccine adjuvants and drug delivery systems for oral dose applications. SPI Pharma offers products in various formulations such as chewables, lozenges, powders and other patient-friendly dosage forms such as swallow tablets, chewable tablets, fast dissolve tablets and soft gelatin capsules. The company also offers contract manufacturing services to other companies. It operates business through manufacturing sites, research and development centers and sales offices located in the UK, Canada, China, France and India. SPI Pharma is headquartered in Wilmington, Delaware, the US.

SPI Pharma Inc Key Recent Developments

Mar 24,2020: SPI Pharma expands Mannogem Mannitol product portfolio to support the development, manufacture and administration of oral dosage forms.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.